Table 1.
Non-annualized medial compartment JSN (Mean ± SD, mm) by treatment group: results in varus and non-varus OA knees
| Varus OA Knees (MAAest <178°) |
Non-varus OA Knees (MAAest ≥178°) |
|||||
|---|---|---|---|---|---|---|
| Doxycycline | Placebo | P* | Doxycycline | Placebo | P* | |
| 16-mo JSN | 0.26 ± 0.39 | 0.36 ± 0.57 | 0.230 | 0.12 ± 0.42 | 0.21 ± 0.52 | 0.080 |
| N of knees | 37 | 45 | 151 | 146 | ||
| 30-mo JSN | 0.49 ± 0.64 | 0.55 ± 0.62 | 0.448 | 0.26 ± 0.58 | 0.42 ± 0.73 | 0.026 |
| N of knees | 35 | 42 | 146 | 138 | ||
Note: Estimated mechanical-axis angle (MAAest) was based on measurement of the anatomic-axis angle [12].
From mixed-effect (repeated measures) linear models adjusted for treatment group, baseline knee pain and JSW, visit (interim or closeout), clinical center, treatment group-clinical center interaction and treatment group-visit interaction.